You are here

  • Home
  • Archive
  • Volume 20, Issue 3
  • Prolonged dual antiplatelet therapy after drug-eluting stent reduces the risk of stent thrombosis and major cardiovascular events but increases the rate of bleeding

Article info

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Prolonged dual antiplatelet therapy after drug-eluting stent reduces the risk of stent thrombosis and major cardiovascular events but increases the rate of bleeding

Authors

  1. Correspondence to : Dr Gérard Helft, Institut de Cardiologie, Pitié-Salpétrière, AP-HP, Paris VI University, 75013 Paris, France; gerard.helft{at}psl.aphp.fr
View Full Text

Citation

Helft G
Prolonged dual antiplatelet therapy after drug-eluting stent reduces the risk of stent thrombosis and major cardiovascular events but increases the rate of bleeding
BMJ Evidence-Based Medicine 2015;20:99.

Publication history

  • First published March 5, 2015.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions